Clinical Research Doctors Drug Development Treatment 
Drug Discovery World
DECEMBER 18, 2023
With a staggering 450,000 clinical trials 3 registered globally to address these pressing health issues, and an average failure rate of 90% 4 , the call to accelerate and revolutionise clinical research is paramount. They mark a significant shift in clinical research, utilising technology to capture real-time patient data.
Drug Target Review
SEPTEMBER 22, 2023
5 Organoids are recognised as New Alternative Methods (NAMs) in drug development. This recognition was codified by the United States Food and Drug Administration (FDA) in 2022 with the signing of the FDA Modernisation Act 2.0 This can aid in the development of safer, more effective therapeutic strategies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Advarra
JUNE 27, 2023
Each phase has a different purpose in testing the treatment’s safety and efficacy. This article explores how the clinical research phases protect study volunteers from harm and ensure new drugs and therapies are developed effectively. Therefore, clinical research is a fundamental aspect of medical advancement.
Drug Discovery World
JUNE 20, 2024
Now, you might wonder: how exactly can these advanced artificial intelligence models propel clinical research forward? In the context of clinical trials, these models can help us add context to insights. Conventional AI models allow us to extract insights from the clinical data but they do lack context.
H1 Blog
MAY 4, 2023
Insights for Thought Leading Stakeholder Engagement to Decrease Medication Non-Adherence Pharmaceutical companies have long recognized the importance of engaging key opinion leaders (KOLs) to gain insight and support for clinical research, drug development, and medical education.
Conversations in Drug Development Trends
NOVEMBER 10, 2023
However, pain treatment shouldn’t resort to a “whatever it takes” approach. Instead, Collaborating with patients plays a fundamental role, as each treatment discussion and decision-making process varies based on individual patients. Pain is not simple; it is not just mere unpleasantness that can be remedied with a pill.
Drug Target Review
FEBRUARY 29, 2024
Through further research and work as a principal investigator on clinical studies for several central nervous system indications, I laid the groundwork for a career in gene therapy drug development. In my current role at Asklepios BioPharmaceutical, Inc. There is still more work to be done to address this skew.
Expert insights. Personalized for you.
147 
Let's personalize your content